Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1)

Experimental Cell Research

Volumn 254, Issue 1, 2000, Pages 64-71

  Wang, Gang ^a   Miskimins, Robin ^a   Miskimins, W Keith ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

cdk2; Cyclin D; Cyclin E; Mimosine; p27(Kip1)

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLINE; MESSENGER RNA; MIMOSINE; PROTEIN P27;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; ENZYME INHIBITION; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0034627859     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4743     Document Type: Article

References (37)

1. Lalande M. A reversible arrest point in the late G1 phase of the mammalian cell cycle. Exp. Cell Res. 186:1990;332-339.
2. Mosca P. J., Dijkwel P. A., Hamlin J. L. The plant amino acid mimosine may inhibit initiation at origins of replication in Chinese hamster cells. Mol. Cell. Biol. 12:1992;4375-4383.
3. Dijkwel P. A., Hamlin J. L. Initiation of DNA replication in the dihydrofolate reductase locus is confined to the early S period in CHO cells synchronized with the plant amino acid mimosine. Mol. Cell. Biol. 12:1992;3715-3722.
4. Gilbert D. M., Neilson A., Miyazawa H., DePamphilis M. L., Burhans W. C. Mimosine arrests DNA synthesis at replication forks by inhibiting deoxyribonucleotide metabolism. J. Biol. Chem. 270:1995;9597-9606.
5. Dai Y., Gold B., Vishwanatha J. K., Rhode S. L. Mimosine inhibits viral DNA synthesis through ribonucleotide reductase. Virology. 205:1994;210-216.
6. Kalejta R. F., Hamlin J. L. The dual effect of mimosine on DNA replication. Exp. Cell Res. 231:1997;173-183.
7. Krude T. Mimosine arrests proliferating human cells before onset of DNA replication in a dose-dependent manner. Exp. Cell Res. 247:1999;148-159.
8. Lin H. B., Falchetto R., Mosca P. J., Shabanowitz J., Hunt D. F., Hamlin J. L. Mimosine targets serine hydroxymethyltransferase. J. Biol. Chem. 271:1996;2548-2556.
9. Hanauske-Abel H. M., Park M. H., Hanauske A. R., Popowicz A. M., Lalande M., Folk J. E. Inhibition of the G1-S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation. Biochim. Biophys. Acta. 1221:1994;115-124.
10. Park M. H., Wolff E. C., Folk J. E. Trends Biochem. Sci. 18:1993;475-479.
11. Alpan R. S., Pardee A. B. p21WAF1/CIP1/SDl1 is elevated through a p53-independent pathway by mimosine. Cell Growth Differ. 7:1996;893-901.
12. Bissonnette N., Hunting D. J. p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene. 16:1998;3461-3469.
13. Gorospe M., Wang X., Holbrook N. J. p53-dependent elevation of p21Waf1 expression by UV light is mediated through mRNA stabilization and involves a vanadate-sensitive regulatory system. Mol. Cell. Biol. 18:1998;1400-1407.
14. Agarwal M. L., Agarwal A., Taylor W. R., Stark G. R. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA. 92:1995;8493-8497.
15. Ji C., Marnett L. J., Pietenpol J. A. Cell cycle re-entry following chemically-induced cell cycle synchronization leads to elevated p53 and p21 protein levels. Oncogene. 15:1997;2749-2753.
16. Friessen A. J., Miskimins W. K., Miskimins R. Cyclin-dependent kinase inhibitor p27kip1 is expressed at high levels in cells that express a myelinating phenotype. J. Neurosci. Res. 50:1997;373-382.
17. Michieli P., Chedid M., Lin D., Pierce J. H., Mercer W. E., Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54:1994;3391-3395.
18. Pagano M., Tam S. W., Theodoras A. M., Beer-Romero P., Del Sal G., Chau V., Yew P. R., Draetta G. F., Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 269:1995;682-685.
19. Hughes T. A., Cook P. R. Mimosine arrests the cell cycle after cells enter S-phase. Exp. Cell Res. 222:1996;275-280.
20. Tsvetkov L. M., Russev G. C., Anachkova B. B. Effect of mimosine on DNA synthesis in mammalian cells. Cancer Res. 57:1997;2252-2255.
21. Millard S. S., Yan J. S., Nguyen H., Pagano M., Kiyokawa H., Koff A. Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest. J. Biol. Chem. 272:1997;7093-7098.
22. Agrawal D., Hauser P., McPherson F., Dong F., Garcia A., Pledger W. J. Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol. Cell. Biol. 16:1996;4327-4336.
23. Alessandrini A., Chiaur D. S., Pagano M. Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia. 11:1997;342-345.
24. Gong J., Traganos F., Darzynkiewicz Z. Growth imbalance and altered expression of cyclins B1, A, E, and D3 in MOLT-4 cells synchronized in the cell cycle by inhibitors of DNA replication. Cell Growth Differ. 6:1995;1485-1493.
25. Singh S. P., Lipman J., Goldman H., Ellis F. H. Jr., Aizenman L., Cangi M. G., Signoretti S., Chiaur D. S., Pagano M., Loda M. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res. 58:1998;1730-1735.
26. Anayama T., Furihata M., Ishikawa T., Ohtsuki Y., Ogoshi S. Positive correlation between p27Kip1 expression and progression of human esophageal squamous cell carcinoma. Int. J. Cancer. 79:1998;439-443.
27. Tan P., Cady B., Wanner M., Worland P., Cukor B., Magi-Galluzzi C., Lavin P., Draetta G., Pagano M., Loda M. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res. 57:1997;1259-1263.
28. Esposito V., Baldi A., De Luca A., Groger A. M., Loda M., Giordano G. G., Caputi M., Baldi F., Pagano M., Giordano A. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res. 57:1997;3381-3385.
29. Yasui W., Kudo Y., Semba S., Yokozaki H., Tahara E. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn. J. Cancer Res. 88:1997;625-629.
30. Cordon-Cardo C., Koff A., Drobnjak M., Capodieci P., Osman I., Millard S. S., Gaudin P. B., Fazzari M., Zhang Z. F., Massague J., Scher H. I. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J. Natl. Cancer Inst. 90:1998;1284-1291.
31. Cote R. J., Shi Y., Groshen S., Feng A. C., Cordon-Cardo C., Skinner D., Lieskovosky G. Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma. J. Natl. Cancer Inst. 90:1998;916-920.
32. Yang R. M., Naitoh J., Murphy M., Wang H. J., Phillipson J., deKernion J. B., Loda M., Reiter R. E. Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J. Urol. 159:1998;941-945.
33. Guo Y., Sklar G. N., Borkowski A., Kyprianou N. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade. Clin. Cancer Res. 3:1997;2269-2274.
34. Sgambato A., Zhang Y. J., Arber N., Hibshoosh H., Doki Y., Ciaparrone M., Santella R. M., Cittadini A., Weinstein I. B. Deregulated expression of p27(Kip1) in human breast cancers. Clin. Cancer Res. 3:1997;1879-1887.
35. Fredersdorf S., Burns J., Milne A. M., Packham G., Fallis L., Gillett C. E., Royds J. A., Peston D., Hall P. A., Hanby A. M., Barnes D. M., Shousha S., O'Hare M. J., Lu X. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc. Natl. Acad. Sci. USA. 94:1997;6380-6385.
36. Porter P. L., Malone K. E., Heagerty P. J., Alexander G. M., Gatti L. A., Firpo E. J., Daling J. R., Roberts J. M. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med. 3:1997;222-225.
37. Catzavelos C., Bhattacharya N., Ung Y. C., Wilson J. A., Roncari L., Sandhu C., Shaw P., Yeger H., Morava-Protzner I., Kapusta L., Franssen E., Pritchard K. I., Slingerland J. M. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer. Nature Med. 3:1997;227-230.